powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1396276861
David Macpherson
M.D.
Ophthalmology
Pasadena,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
Healthparse Signals
Monitor this provider for changes — dated NPI change events
QUALITY · MIPS · 2024
Final MIPS score
94.8
Quality
84.0
Cost
82.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.83%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$165
Payment records
9
By payment type
Food and Beverage
$165
Top paying entities
Food and Beverage
$165
PRESCRIBING · PART D · 2024
Total Rx claims
776
Beneficiaries
—
Total drug cost
$609K
Distinct drugs
7
Brand share
88.1%
Top prescribed drugs
Perfluorohexyloctane/Pf
239 claims
Cyclosporine
226 claims
Cyclosporine
78 claims
Lifitegrast
76 claims
Neomycin/Polymyxin B/Dexametha
51 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
531
Unique beneficiaries
—
Total services
706
Distinct HCPCS
11
Medicare payment
$57K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,144 Ophthalmology providers in CA — below median (cohort median 1,859).
